P1.013 | American Academy of Neurology (AAN) - 73rd Annual Meeting | 2021 EMBARK: A Phase 3b, open-label,single-arm, safety study to evaluate the long-term safety and efficacy of aducanumab in eligible participants with Alzheimer s disease Castrillo-Viguera C1, Chalkias S1, Burkett PR1, Wu S1, Chen H1, Harrison K1, Yurgalevitch C1, and Budd Haeberlein S1 1Biogen, Cambridge, MA, USA Disclosures: CCV, SC, PB, SW, HC, KH, CY and SBH are employees and shareholders of Biogen. This study was sponsored by Biogen (Cambridge, MA, USA). Writing and editorial support for the preparation of this poster was provided by Nucleus Global (Atlanta, GA, USA): funding was provided by Biogen.
iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Abbott Laboratories (NYSE:ABT) - The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Common MS Treatment Wears Off More Quickly in Black Patients
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Global Stroke Care Takes a Hit During the Pandemic
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Half of Kids with Inflammatory Syndrome After COVID-19 Have Neurologic Symptoms
mesabitribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mesabitribune.com Daily Mail and Mail on Sunday newspapers.